Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
October 15, 2025
Top Women’s Health News: Video summary (Oct 1 – Oct 14, 2025)
October 15, 2025
Lucid Diligence Brief: Kailera Therapeutics $600m Series B
October 14, 2025
Neuroscience Today: Roche & Lilly Lead in Alzheimer’s (Oct 7 –14, 2025)
October 14, 2025
Top Obesity News: Video summary (Sept 30 – Oct 14, 2025)
October 14, 2025
Obesity Today: Chugai licenses CT-388 for Japan, GLP-1 access news (Oct 7–14, 2025)
October 14, 2025
Endocrinology Today : SMOC1 impact on T2D and more breakthroughs (Oct 7–14, 2025)
October 14, 2025
Lucid Diligence Brief: Excellergy ECRIs, $70M investment
October 13, 2025
Top Oncology News: Video summary (Sept 29 – Oct 13, 2025)
October 13, 2025
Hematology Today: CAR-T, Gene Therapy and Radioconjugates (Oct 6–13, 2025)
October 13, 2025
Oncology Today: ADCs, PD-L1 & FDA Wins (Oct 6–13, 2025)
October 13, 2025
AI in Healthcare and Digital Health Today (Oct 6–13, 2025)
October 13, 2025